Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?

Keating NL, Landrum MB, Klabunde CN, Fletcher RH, Rogers SO, Doucette WR, Tisnado D, Clauser S, Kahn KL.

J Clin Oncol. 2008 May 20;26(15):2532-7. doi: 10.1200/JCO.2007.15.9434.

PMID:
18487570
2.

Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).

Jett JR, Schild SE, Keith RL, Kesler KA; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):266S-276S.

PMID:
17873173
3.

Management of unresected stage III non-small cell lung cancer: a systematic review.

Okawara G, Mackay JA, Evans WK, Ung YC; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

J Thorac Oncol. 2006 May;1(4):377-93. Review.

4.

The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.

Mao J, Kocak Z, Zhou S, Garst J, Evans ES, Zhang J, Larrier NA, Hollis DR, Folz RJ, Marks LB.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1360-9. Epub 2007 Feb 2.

5.

Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?

Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF.

Lung Cancer. 2005 Apr;48(1):93-102.

PMID:
15777975
6.

Measuring the quality of physician practice by using clinical vignettes: a prospective validation study.

Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M.

Ann Intern Med. 2004 Nov 16;141(10):771-80.

PMID:
15545677
7.

Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium.

Ayanian JZ, Chrischilles EA, Fletcher RH, Fouad MN, Harrington DP, Kahn KL, Kiefe CI, Lipscomb J, Malin JL, Potosky AL, Provenzale DT, Sandler RS, van Ryn M, Wallace RB, Weeks JC, West DW.

J Clin Oncol. 2004 Aug 1;22(15):2992-6. No abstract available. Erratum in: J Clin Oncol. 2004 Dec 15;22(24):5026.

PMID:
15284250
8.

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, Olak J, Stover D, Strawn JR, Turrisi AT, Somerfield MR; American Society of Clinical Oncology.

J Clin Oncol. 2004 Jan 15;22(2):330-53. Epub 2003 Dec 22. Review. No abstract available.

PMID:
14691125
9.

Radiotherapy patterns of care study in lung carcinoma.

Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J.

J Clin Oncol. 2003 Dec 15;21(24):4553-9. Epub 2003 Nov 3.

PMID:
14597743
10.

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR; North Central Cancer Treatment Group.

J Clin Oncol. 2003 Sep 1;21(17):3201-6. Epub 2003 Jul 21.

PMID:
12874270
11.

Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.

Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM.

Radiother Oncol. 2003 Jun;67(3):275-83.

PMID:
12865175
12.

Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.

Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):114-20.

PMID:
12694829
13.

Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer.

Lee JS, Scott CB, Komaki R, Ettinger DS, Sause WT.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):362-70.

PMID:
11872281
14.

Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.

Rocha Lima CM, Herndon JE 2nd, Kosty M, Clamon G, Green MR.

Cancer. 2002 Jan 1;94(1):181-7.

15.

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Hillner BE, Smith TJ, Desch CE.

J Clin Oncol. 2000 Jun;18(11):2327-40. Review.

PMID:
10829054
16.

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.

Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, Emami B, Curran W Jr, Byhardt R, Dar AR, Turrisi A 3rd.

Chest. 2000 Feb;117(2):358-64.

PMID:
10669675
17.

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1143-9.

PMID:
10613306
18.

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y.

J Clin Oncol. 1999 Sep;17(9):2692-9.

PMID:
10561343
19.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR.

J Natl Cancer Inst. 1996 Sep 4;88(17):1210-5.

PMID:
8780630
20.

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.

Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY, Laplanche A.

J Natl Cancer Inst. 1991 Mar 20;83(6):417-23.

PMID:
1847977

Supplemental Content

Support Center